White House, Novo Nordisk and Eli Lilly
Digest more
GlobalData on MSN
Eli Lilly to invest $3bn in new Dutch manufacturing facility
Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist ...
Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...
Eli Lilly shares are trading higher on Monday. The pharmaceutical giant announced a significant European manufacturing expansion.
U.S. sales of Lilly’s weight-loss treatment Zepbound nearly tripled, to $3.57 billion, in the third quarter. Meanwhile, ...
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply ...
US pharma group says region’s use of ‘one-way insurance system’ to keep down prices is not fair on the industry ...
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A ...
Weight loss drugs are set to become a disproportionate share of Lilly's business.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results